A single-center observational study on the clinical prognosis of patients secondary to infection of pancreatic necrosis with different recovery of immune function

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000028865

Enrollment

Unknown

Registered

2020-01-05

Start date

2020-02-01

Completion date

Unknown

Last updated

2020-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

severe acute pancreatitis

Interventions

Early immune function recovery group:None

Delayed immune function recovery :None

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: All adult patients (aged >18 years) with a primary diagnosis of SAP admitted to the surgical intensive care unit (SICU) of Jinling Hospital underwent IPN and sepsis.

Exclusion criteria

Exclusion criteria: (1) Pregnant or lactating women; (2) Patient in dying condition; (3) Patient with comorbidities related to the immune system or treatment interfering with the immune system; (4) Patient with cancer.

Design outcomes

Primary

Measure	Time frame
human leukocyte antigen DR;neutrophil CD88;Regulatory T lymphocytes;	—

Secondary

Measure	Time frame
acute physiology and chronic health evaluation (APACHE) II score;Length of stay;28-day mortality;Quality of life scale;	—

Countries

China

Contacts

Public ContactTong Zhihui

Jinling Hospital affiliated to Nanjing University

njzyantol@hotmail.com+86 13851948781

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026